Target intelligence / Profile preview

General skin proteins

Molecular classification
Other
01

Overview

General skin proteins is a collective term for the various structural and functional proteins that constitute the skin's layers, primarily the epidermis and dermis. Key members include keratins, which form the intermediate filaments of the cytoskeleton in epithelial cells, and collagen and elastin, which provide the extracellular matrix with tensile strength and recoil properties (StatPearls, "Physiology, Skin"). Other significant proteins include filaggrin, which is vital for the assembly of the skin barrier and the production of natural moisturizing factors (NCBI, "The Skin Barrier"). In a clinical context, these proteins are often the indirect or non-specific targets of topical agents designed to enhance barrier function, promote wound healing, or mitigate the effects of aging. For example, keratolytics like salicylic acid work by breaking down keratin aggregates to treat hyperkeratotic conditions. Because this term refers to a broad class rather than a single molecular entity, it is generally considered a descriptive category in pharmacology rather than a specific drug target. Therapeutic strategies involving these proteins often focus on replacing lost components, such as collagen fillers, or protecting existing structures from environmental degradation. Monitoring the integrity of these proteins is essential in managing chronic skin diseases like atopic dermatitis and psoriasis.

Other names
Dermal proteinsEpidermal proteinsSkin structural proteinsCutaneous proteinsSkin proteins
02

Mechanism of action

Non-specific modulation of skin structural integrity and barrier function through physical protection, hydration, and keratolysis.

03

Biological functions

Barrier functionStructural integritySkin hydrationProtection
04

Disease associations

DermatitisPsoriasisSkin agingIchthyosisWound healing
05

Safety considerations

Skin irritationContact dermatitisSystemic absorption through compromised barrier
06

Interacting drugs

Salicylic acid

3 more in the full profile.

07

Biomarkers

Transepidermal water loss (TEWL)Filaggrin expressionCollagen density

Beyond the preview

Go deeper on General skin proteins.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on General skin proteins.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call